Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Jul 31, 2023 7:27pm
229 Views
Post# 35565754

RE:RE:RE:bought deal why?

RE:RE:RE:bought deal why?
Hello Canadafan and curious about a couple things that you mentioned. As for the units in the offering, they will be able to separate the warrants from the stock and they can trade separate....I know this as when CC offered a similar deal I was able to pick up a bunch of the warrants on the open market when they became available but expired last year as onc would not extend the warrants and everyone said they did not want the overhang of the warrants because of the dilution but now we have that again....Hopefully this time is different but the units will be divided and can sell separate I believe as this is what happened in the past.
You also mentioned that once the deal closed that onc will be sitting on near $2 ps in cash, that would be over 120 million dollars and I do not think that will be their cash on hand so hoping you might clarify that figure and thanks.
<< Previous
Bullboard Posts
Next >>